Posted by Michael Wonder on 24 Jun 2024
Expanded PBS listings for lung cancer and a chronic skin disease
24 June 2024 - Australians with non-small cell lung cancer and the chronic skin disease hidradenitis suppurativa, now have access to expanded treatment options under the PBS.
Osimertinib (Tagrisso) has been expanded for use as additional therapy after surgery for patients with epidermal growth factor receptor mutation positive early-stage non-small-cell lung cancer.
